NP
GNOM icon

NorthRock Partners’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

NorthRock Partners’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-54
Closed -$1.71K – 771
2025
Q1 		$1.71K Buy
+54
New +$2.05K ﹤0.01% 831
2024
Q4 		– Sell
-54
Closed -$2.42K – 814
2024
Q3 		$2.42K Buy
+54
New +$2.41K ﹤0.01% 803

Other funds holding GNOM

FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IA
Insight Advisors Newtown, Pennsylvania $567M AUM 25.52% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return

NorthRock Partners's GNOM Position: Q2 2025 in Review

NorthRock Partners sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q2 2025, closing a stake of 54 shares — an estimated $1.71K sold.

NorthRock Partners first reported a position in GNOM in Q3 2024 and held it in 2 quarters. The position peaked at $2.42K in Q3 2024. 53 funds tracked by Wall St. Rank hold GNOM as of Q2 2025.

  • NorthRock Partners reported no remaining Global X Genomics & Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • NorthRock Partners sold 54 Global X Genomics & Biotechnology ETF shares in Q2 2025, an estimated $1.71K.
  • NorthRock Partners first reported a position in Global X Genomics & Biotechnology ETF in Q3 2024 and held it in 2 quarters.
  • NorthRock Partners's Global X Genomics & Biotechnology ETF position peaked at $2.42K in Q3 2024.
  • 53 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2025.

Based on NorthRock Partners's 13F filing for Q2 2025, filed 25 Jul 2025.